Get started
Author

R. Jeffrey Karnes

Observed names: Karnes, Robert Jeffrey, R Jefferey Karnes, R Jeffrey Karnes, R. J. Karnes, R. Jefferey Karnes, R. Karnes, R.J. Karnes, Robert Jeffrey Karnes
OpenAlex ID: A5108098482
Prostate Cancer, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology
2025 · Daniel E. Spratt, Sandy Srinivas, et al. · Journal of the National Comprehensive Cancer Network · 124
The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer
2021 · Neha Singh, Varune R. Ramnarine, et al. · Nature Communications · 106
PDF
The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications
2018 · Varune Rohan Ramnarine, Mohammed Alshalalfa, et al. · GigaScience · 74
Use of High Fidelity Operating Room Simulation to Assess and Teach Communication, Teamwork and Laparoscopic Skills: Initial Experience
2009 · Matthew T. Gettman, Claudio W. Pereira, et al. · The Journal of Urology · 63
Urology Resident Training With an Unexpected Patient Death Scenario: Experiential Learning With High Fidelity Simulation
2008 · Matthew T. Gettman, R. Jeffrey Karnes, et al. · The Journal of Urology · 37
18F-FDG PET/CT and Urothelial Carcinoma: Impact on Management and Prognosis—A Multicenter Retrospective Study
2019 · Fabio Zattoni, Elena Incerti, et al. · Cancers · 32
PDF
Chromosomal Alterations Detected by Fluorescence In Situ Hybridization in Urothelial Carcinoma and Rarer Histologic Variants of Bladder Cancer
2008 · Benjamin R. Kipp, Harmony L. Tyner, et al. · American Journal of Clinical Pathology · 30
NCCN Guidelines® Insights: Prostate Cancer, Version 5.2026
2026 · Daniel E. Spratt, Sandy Srinivas, et al. · Journal of the National Comprehensive Cancer Network · 11
PDF
Transitional cell carcinoma recurrence impacting intestinal diversion after radical cystectomy. Oncologic outcomes of a rare site of recurrence
2020 · Fabio Zattoni, Iliana Bednarova, et al. · Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication · 6
Salvage cryotherapy versus salvage radical prostatectomy for radiorecurrent prostate cancer: Long-term oncologic outcomes
2019 · S.M. Nair, T. Lyon, et al. · European Urology Supplements · 4
1870 Alvimopan, a Peripherally Acting Mu-opioid Receptor Antagonist, Accelerates Gastrointestinal Recovery and Decreases Length of Hospital Stay After Radical Cystectomy
2013 · Ashish M Kamat, Sam S Chang, et al. · The Journal of Urology · 4
Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancer
2025 · Udit Singhal, Ralph Jiang, et al. · Prostate Cancer and Prostatic Diseases · 2
PDF
Timing of treatment for muscle-invasive bladder cancer in the neo-adjuvant chemotherapy era
2020 · Giovanni Motterle, R. Jeffrey Karnes · AME Medical Journal · 2
Evaluation of Response to 177lu-psma-617 by Site Specific Disease in Metastatic Castrate-resistant Prostate Cancer
2025 · Mohamed E. Ahmed, Giuseppe Reitano, et al. · Urologic Oncology Seminars and Original Investigations · 1
Radical prostatectomy versus radiotherapy in M1a and low volume M1b prostate cancer patients: an indirect comparison with the STAMPEDE trial arm H
2020 · G. Gandaglia, A. Heidenreich, et al. · European Urology Open Science · 1
Mp69-20 the Impact of Proton-pump Inhibitors on Outcomes Following Radical Prostatectomy
2016 · Mary E. Westerman, Vidit Sharma, et al. · The Journal of Urology · 1
PDF
Impact of Prior Radical Prostatectomy on Response to 177 PSMA-Lutetium Therapy and Survival Outcomes in Metastatic Castration-Resistant Prostate Cancer
2026 · Eman Ahmed, Jack Andrews, et al. · Research Square
PDF
An artificial intelligence algorithm characterizes the deterioration of body composition from systemic therapy for patients with advanced prostate cancer
2026 · Chloe Shi, Nancy Wei, et al. · JNCI Journal of the National Cancer Institute
Ten-year outcomes of PET-directed salvage nodal radiotherapy and temporary ADT for N1 and M1a hormone-sensitive prostate cancer
2026 · Cristian J. Salazar V, Tyler J. Wilhite, et al. · Practical Radiation Oncology
Salvage prostatectomy for locally recurrent prostate cancer after radiation: a narrative review of indications, outcomes, and surgical advancements
2026 · Matthew S. Lee, R. Jeffrey Karnes · World Journal of Urology
Outcomes of Patients With Favorable Intermediate Risk Gleason Grade Group 2 Prostate Cancer Undergoing Radical Prostatectomy in the MRI Era: Refining Active Surveillance Selection Criteria
2026 · Eric V. Li, Eman E. Ahmed, et al. · The Prostate
Characterizing the Activity of Inflammasome‐Related Genes and Their Association With Oncological Outcomes in Prostate Cancer
2026 · Alireza Ghoreifi, Mohammed Alshalalfa, et al. · The Prostate
Salvage lymph node dissection in oligo-recurrent prostate cancer patients: Mapping patterns of recurrence and factors associated with disease progression
2026 · Mohamed E. Ahmed, Eman E. Ahmed, et al. · Urologic Oncology Seminars and Original Investigations
Ip62-22 Genomic Classifier Results and Use of Post-prostatectomy Treatment Among a National Cohort of Patients With Prostate Cancer
2026 · Michael S. Leapman, Qi J. Xu, et al. · The Journal of Urology
Ip50-05 Using Artificial Intelligence to Distinguish Low Grade Urothelial Carcinoma From Benign Pathology on Turbt Surgical Video
2026 · Abhinav Khanna, Karin Lifshitz, et al. · The Journal of Urology
Works count: 56
Citation count: 498
H-index: 8
I10-index: 8
Year
Topic
Type